Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-5.38
↑ 86% vs avg
Percentile
P56
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-38.36
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -5.38 | -887.8% |
| 2024 | -0.54 | +89.0% |
| 2023 | -4.95 | -74.7% |
| 2022 | -2.83 | +68.8% |
| 2021 | -9.08 | -14.0% |
| 2020 | -7.97 | +42.4% |
| 2019 | -13.83 | -161.2% |
| 2018 | -5.30 | +94.6% |
| 2017 | -98.95 | +57.9% |
| 2016 | -234.79 | - |